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Summary
Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are major phospholipids in mammalian membranes. In liver,
PC is synthesized via the choline pathway or by methylation of PE via phosphatidylethanolamine N-methyltransferase
(PEMT). Pemt2/2 mice fed a choline-deficient (CD) diet develop rapid steatohepatitis leading to liver failure. Steatosis is
observed in CD mice that lack both PEMT and multiple drug-resistant protein 2 (MDR2), required for PC secretion into
bile. We demonstrate that liver failure in CD-Pemt2/2 mice is due to loss of membrane integrity caused by a decreased
PC/PE ratio. TheCD-Mdr22/2/Pemt2/2mice escape liver failure bymaintaining a normal PC/PE ratio.Manipulation of PC/PE
levels suggests that this ratio is a key regulator of cell membrane integrity and plays a role in the progression of steatosis
into steatohepatitis. The results have clinical implications as patients with nonalcoholic steatohepatitis have a decreased
ratio of PC to PE compared to control livers.Introduction
The rapid rise in obesity has caused an epidemic of nonalcoholic
fatty liver disease associated with insulin resistance and the
metabolic syndrome. Little is known, however, concerning the
requirements for progression of steatosis to steatohepatitis
(Cortez-Pinto et al., 2006). This paper provides insight into
how a change of phospholipid composition in the liver can
lead to steatohepatitis and liver failure.
The reason membrane bilayers have a defined phospholipid
composition is not clear. Phosphatidylcholine (PC) and phos-
phatidylethanolamine (PE) are two major phospholipids that
are asymmetrically distributed in the plasma membrane: the
majority of PC is localized to the outer leaflet, whereas PE is en-
riched in the inner leaflet (Devaux, 1991). PC homeostasis in the
liver is regulated by PC anabolism and catabolism, as well as
by PC secretion and uptake (Figure 1A). Hepatic PC is made
from choline via the CDP-choline pathway and also by PE N-
methyltransferase (PEMT), which converts PE to PC via 3 meth-
ylation reactions (Vance, 2002). PC secretion into bile is medi-
ated by a PC-specific flippase, multiple drug-resistant protein
2 (MDR2), in the hepatic canalicular membrane (Smit et al.,
1993). Mice lacking PEMT develop steatohepatitis and hyper-
acute liver failure within 3 days of starting a choline-deficient
(CD) diet (Walkey et al., 1998). However, mice lacking both
MDR2 and PEMT are resistant to liver failure and steatohepatitis
observed in the CD-Pemt2/2 mice and survive for at least 3
months with steatosis when fed the CD diet (Li et al., 2005).
Mdr22/2miceshowed intrahepatic cholestasis and liver damage
atw35 weeks after birth (Smit et al., 1993), whereas Mdr22/2/
Pemt2/2mice did not for up to 15 weeks after birth.CELL METABOLISM 3, 321–331, MAY 2006 ª2006 ELSEVIER INC. DWe report that Pemt2/2mice experience liver failure when fed
theCDdiet because the ratio of PC to PE is decreased by >50%,
which leads to loss of membrane integrity with ballooning hepa-
tocytes, and the resultant cell damage recruits an inflammatory
response typical of steatohepatitis. This mouse model appears
relevant to human disease since we found that patients with
nonalcoholic steatohepatitis (NASH) also have a diminished
PC/PE ratio within the liver. These results have broad implica-
tions for management of patients with acute liver failure or
chronic liver disease associated with steatohepatitis.
Results
Liver failure is associated with a decreased ratio
of PC to PE
Rapid depletion of hepatic PC by 50% via biliary secretion was
originally suggested as the cause of hyperacute liver failure in
CD-Pemt2/2mice (Walkey et al., 1998). However, CD-Mdr22/2/
Pemt2/2mice also have anw50% reduction in hepatic PC (Fig-
ure 1B) but do not develop liver failure. Triacylglycerols accu-
mulate in livers of CD-Pemt2/2 mice and to a greater extent in
CD-Mdr22/2/Pemt2/2 mice (Table 1). Thus, liver damage is in-
dependent of the decrease in hepatic PC and fat accumulation.
An important difference between Pemt2/2mice andMdr22/2/
Pemt2/2mice is the hepatic PE content during choline depriva-
tion. In Mdr22/2/Pemt2/2 mice, the CD diet decreased hepatic
PC and PE to a similar extent (Figure 1C). In contrast, in Pemt2/2
mice, the CD diet decreased hepatic PC by 50%, whereas PE
remained unchanged (Figure 1B). Thus, the CD diet reduced
the PC:PE ratio by 57% in Pemt2/2 mice but by only 17% inOI 10.1016/j.cmet.2006.03.007 321
A R T I C L EFigure 1. Hepatic failure is not associated with a de-
creased PC level but with a decreased PC/PE ratio
A) Phosphatidylcholine (PC) homeostasis in the liver.
Four PC acquisition pathways are indicated. In the
liver, 70% of PC is biosynthesized from choline via
the CDP-choline pathway, whereas 30% of PC is
derived from phosphatidylethanolamine (PE) via
the phosphatidylethanolamine N-methyltransferase
(PEMT) pathway. PC can also be derived from reac-
ylation of lysoPC. High-density lipoproteins (HDL)
and low-density lipoproteins (LDL) transport not
only neutral lipids but also phospholipids (mainly
PC) into the liver. PC provides choline for sphingo-
myelin (SM) synthesis and is a precursor of phospha-
tidylserine (PS). A major loss of hepatic PC occurs
from biliary secretion mediated by multiple drug-re-
sistant protein 2 (MDR2). In addition to the degrada-
tion of PC by phospholipases, hepatic PC can also
be secreted as an important component of very
low-density lipoproteins (VLDL) and HDL.
B) Levels of PC, PE, and sphingomyelin (SM) in liver
homogenates obtained from Pemt2/2 mice and
Mdr22/2/Pemt2/2 mice fed a CS diet for 24 hr and
then fed a choline-deficient (CD) diet for 3 (CD3) or
21 (CD21) days. Values are averages 6 SD; *, p <
0.05; **, p < 0.001, comparing CS to CD groups.
C)Molar ratio of PC to PE in CS and CDmice. Values
are averages 6 SD; *, p < 0.05; **, p < 0.001.
D) Correlation between hepatic PC/PE ratio and
plasma ALT activity. Each point represents averages
of 6–8 mice.Mdr22/2/Pemt2/2mice (Figure 1C). The decrease in PC/PE ratio
in CD-Pemt2/2 mice coincided with an increase in the plasma
level of alanine aminotransferase (ALT) (Li et al., 2005). The
strong correlation (r = 0.95) between the PC/PE ratio and plasma
ALT activity (Figure 1D) suggests that liver damage in CD-
Pemt2/2 mice might be associated with a decreased PC/PE
ratio. Hepatic cholesterol (Table 1) and sphingomyelin (SM) (Fig-
ure 1B), major plasmamembrane lipids, did not change in either
mouse model fed the CD diet. Moreover, no liver damage was
observed in wild-type mice fed the CD diet for up to 21 days,
and the hepatic PC/PE ratio was unaffected, although hepatic
PC and PE levels both decreased byw28% (data not shown).
One explanation for the induction of liver damage by the CD
diet is that increased plasma bile acids might have been detri-
mental to plasma membrane integrity. However, plasma bile
acid levels were not increased by the CD diet in either Pemt2/2
or Mdr22/2/Pemt2/2 mice (Table 1). Another explanation for
the liver damage might be that alterations in phospholipid levels
in the plasmamembrane had reduced plasmamembrane integ-
rity. Plasma membranes were isolated from hepatocytes of CD-
Pemt2/2 and CD-Mdr22/2/Pemt2/2 mice. Specific activities of
50-nucleotidase in plasmamembrane fractions and total liver ho-
mogenates were 56.4 and 3.8 mmol/h/mg protein, respectively.322Specific activities of the ER marker NADPH:cytochrome C re-
ductase in plasma membrane fractions and total liver homoge-
nates were 0.4 and 48.5 nmol/min/mg protein, respectively.
Thus, there was significant purification of plasma membrane.
The concentrations of PC, PE, and SM were determined (Fig-
ures 2A and 2B). The relative amount of SM compared to PC
is also consistent with purified plasma membranes. A striking
correlation (r = 0.97) was observed between the PC/PE ratio in
plasmamembranes and plasmaALT activity (Figure 2C). Neither
the genotype nor the CD diet affected the plasma membrane
level of SM (Figure 2A). Although the CD diet decreased the
PC content of livers of Pemt2/2 mice byw50%, the amount of
total lipids in the hepatocyte plasmamembranes was not signif-
icantly affected (Table 1).
A change inmembrane fluidity might cause variations inmem-
brane integrity and functions of membrane proteins (Lang et al.,
1998). We assessed the fluidity of hepatocyte plasma mem-
branes using a fluorescent probe, 1-(4-trimethylammonium-
phenyl)-6-phenyl-1,3,5-hexatriene p-tolunesulfonate and found
that the CD diet reduced the polarization value from 0.23 to 0.17
(P < 0.05) of hepatocyte plasma membranes in the Pemt2/2 but
not in Mdr22/2/Pemt2/2 mice, consistent with the decreased
PC/PE ratio (Figure 2B).Table 1. Factors potentially influencing membrane integrity
Pemt2/2, CS Pemt2/2, CD3 Mdr22/2/ Pemt2/2, CS Mdr22/2/ Pemt2/2, CD21
Hepatic TG (mg/mg protein) 105.3 6 41.9 578.9 6 122.5* 17.3 6 9.2 962.2 6 171.7*
Hepatic Ch (nmol/mg protein) 14.9 6 0.9 15.4 6 2.9 14.2 6 2.3 17.2 6 2.2
Plasma Memb. Ch (nmol/mg protein) 158.7 6 14.2 173.3 6 1.3 146.4 6 15.3 177.5 6 12.6
Plasma Memb. Total Lipids (PL + Ch) (nmol/mg protein) 431.3 6 23.7 431.2 6 28.3 413.7 6 17.3 380.3 6 9.6
Plasma Bile Acids (mmol/l) 10.0 6 7.4 16.1 6 6.9 17.9 6 8.1 13.8 6 3.8
Plasma bile acids were analyzed. Neutral lipids in liver homogenates and plasma membrane were extracted and analyzed by gas-liquid chromatography. TG, triacylgly-
cerol; Ch, cholesterol; PL, phospholipid; Memb., membrane; CS, choline-supplemented; CD, choline-deficient for 3 or 21 days. *, p < 0.05; Data =mean for 6–8mice6 SD.CELL METABOLISM : MAY 2006
PC/PE ratio and steatohepatitisFigure 2. Dependence of plasma membrane integrity on PC/PE ratio of hepatocytes
A) Phospholipid content of hepatocyte plasmamembranes from Pemt2/2mice andMdr22/2/Pemt2/2mice fed the CS diet for 24 hr and then fed the choline-deficient (CD)
diet for 2, 3, or 21 (CD2, CD3, or CD21) days. Data are averages 6 SD from 3 mice in each group. *, p < 0.05; **, p < 0.01, for CS versus CD mice.
B) The PC/PE ratio in hepatocyte plasmamembranes. x, Pemt2/2mice fed the CD diet for 2 days andMdr22/2/Pemt2/2mice fed the CD diet for 3 days. Data are averages
6 SD from 3 mice in each group. *, p < 0.05; **, p < 0.01, for CS versus CD mice.
C) Correlation between plasma membrane PC/PE ratio and plasma ALT activity. Each point represents averages of 6–8 mice.
D) PE exposure on the cell surface. Hepatocytes from 3 Pemt2/2 mice and 3 Mdr22/2/Pemt2/2mice fed the CS or CD diet were incubated with biotinylated PE-specific
binding peptide, Ro98-019, at 4ºC for 30 min and subsequently with FITC-conjugated streptavidin for 30 min and then viewed with a fluorescence microscope.
E) Hypothetical mechanism for liver failure in CD-Pemt2/2 mice. PCs form cylindrical structures and PEs form conical structures. If the proportion of these two lipids is
changed significantly with an increase in conical structures, the membrane might leak.Since the PC/PE ratio is strikingly lower in CD-Pemt2/2 mice
than in CD-Mdr22/2/Pemt2/2 mice, we determined if more PE
were exposed on the cell surface of CD-Pemt2/2 hepatocytes.
Figure 2D shows a 3-fold increase in relative fluorescent inten-
sity of PE in hepatocytes from Pemt2/2 mice fed the CD diet
for 2 days (P < 0.05), but no change in Mdr22/2/Pemt2/2 mice
fed the CD diet for 3 (data not shown) or 21 days.
These data suggest a strong link between liver damage and
the PC/PE ratio in the plasma membrane. We hypothesize that
changes in membrane structure induced by increased PE expo-CELL METABOLISM : MAY 2006sure on the cell surface caused a loss of membrane integrity
(Figure 2E). An increased content of the cone-shaped, nonbi-
layer-forming lipid, PE, in the outer monolayer of the plasma
membrane may result in membranes that are not as closely
packed as those formed by PC, which has a cylindrical shape
(Dowhan and Bogdanov, 2002). The maintenance of a normal
PC/PE ratio ofw1.5 to 1.8 in the livers of CD-Mdr22/2 /Pemt2/2
would favor retention of membrane integrity, whereas a ratio
of <1.0, as found in CD-Pemt2/2mice, would result in disruption
of membrane integrity.323
A R T I C L EMechanism for maintenance of the PC/PE ratio
in CD-Mdr22/2/Pemt2/2 mice
We investigated the mechanism for the decline in PE when
the Mdr22/2/Pemt2/2 mice were fed the CD diet. The rate of
[3H]glycerol incorporation into PEwasw1.8-fold higher in hepa-
tocytes from CD- compared to CS-Mdr22/2/Pemt2/2 mice. In
contrast, the rate of catabolism of [3H]PE was enhanced w3-
fold by the CD diet (Figure 3A). Thus, the decreased content
of PE in CD-Mdr22/2/Pemt2/2 mice likely resulted from an im-
balance between PE biosynthesis and degradation.
When mice of both genotypes were fed the CD diet, the levels
of hepatic PC decreased. Hepatic PC is secreted into bile, into
lipoproteins, and is metabolized intracellularly (Figure 1A). We
attributed the rapid decline in hepatic PC in CD-Pemt2/2 mice
to PC secretion into bile (Li et al., 2005). However, since no
PC is secreted into bile by Mdr22/2/Pemt2/2 mice, we investi-
gated the mechanism for the decrease of PC upon feeding the
Mdr22/2/Pemt2/2 mice the CD diet. The amount of hepatic
PC derived from HDL is similar to the amount of PC secreted
in VLDL (Jeong et al., 1998). The rate of VLDL-PC secretion is
decreased by choline deprivation in hepatocytes isolated from
both mouse models, but the rate of HDL-PC uptake is not
changed by the CD diet (Figure 3B). Thus, choline deprivation
does not enhance PC loss from hepatocytes via lipoprotein
metabolism.
Another possibility for a decreased PC/PE ratio in Pemt2/2
mice is that PE biosynthesis was not decreased in response to
choline deprivation, whereas it might be in Mdr22/2/Pemt2/2
mice. PE is made in mammalian cells by the CDP-ethanolamine
pathway and by the decarboxylation of phosphatidylserine
(Vance, 2002). The activity of CTP:phosphoethanolamine cyti-
dylyltransferase (ET), the rate-limiting enzyme in the CDP-etha-
nolamine pathway, was the same in Pemt2/2 and Mdr22/2/
Pemt2/2 hepatocytes (3 nmol/min/mg protein) and was unaf-
fected by the CD diet. Thus, the rate of PE biosynthesis from
the CDP-ethanolamine pathway appears to be independent of
the genotype and dietary choline status of the mice.
A likely mechanism for the decrease in PC content in hepato-
cytes from CD-Mdr22/2/Pemt2/2mice is increased PC catabo-
lism. We previously found that phospholipase A2 (PLA2) activity
and PC degradation are increased by choline deprivation of
Mdr22/2/Pemt2/2 mice, but not Pemt2/2 mice (Li et al., 2005).
We now show that the activities of both calcium-dependent
PLA2 (cPLA2) and calcium-independent PLA2 (iPLA2) are en-
hanced by choline deprivation in Mdr22/2/Pemt2/2 but not in
Pemt2/2 hepatocytes (Figure 3C). Indeed, there is a striking de-
crease in cPLA2 in Pemt
2/2 hepatocytes. The increase in PLA2
activity in the livers of CD-Mdr22/2/Pemt2/2 mice was dimin-
ished by the PLA2 inhibitors, BEL (an iPLA2-specific inhibitor)
and ATK (an inhibitor of both iPLA2 and cPLA2) (data not shown),
confirming that the activity measured was PLA2. Therefore,
rapid depletion of hepatic PC in CD-Pemt2/2 mice resulted
from continued secretion of PC into bile (Li et al., 2005), whereas
the loss of hepatic PC in CD-Mdr22/2/Pemt2/2mice can be at-
tributed to increased PC catabolism. Hence, different regulatory
mechanisms for depletion of PC from the liver alter PE metabo-
lism in Pemt2/2 mice and Mdr22/2/Pemt2/2 mice. As a result,
Mdr22/2/Pemt2/2 mice maintain the PC/PE ratio and mem-
brane integrity in hepatocyte plasma membranes, escape liver
failure, and adapt to choline deprivation by balancing the catab-
olism of PC and PE.324The ratio of PC to PE is a key regulator of membrane
integrity
To determine if a decreased PC/PE ratio leads to loss of mem-
brane integrity, we prepared large unilamellar vesicles with dif-
ferent PC/PE ratios. A fluorescent molecule, calcein, is quenched
when entrapped in vesicles. Fluorescence is observed upon cal-
cein leakage from the vesicles. A decreased PC/PE ratio en-
hanced the release of calcein from the vesicles (Figure 4A), indi-
cating that the low PC/PE ratio in CD-Pemt2/2 hepatocytes
might be responsible for inducing membrane permeability.
Figure 3. The mechanism by which a normal PC/PE ratio is maintained in hepato-
cytes from CD-Mdr22/2/Pemt2/2 mice
A) The rates of PE synthesis and degradation were estimated from pulse-chase la-
beling with [3H]glycerol of primary cultured hepatocytes from 3Mdr22/2/Pemt2/2
mice fed the CS diet for 24 hr and then fed the choline-deficient (CD) diet for 21
days (CD21). Relative rates are based on comparisons between CS and CD
mice. Values are averages 6 SD.
B) VLDL-PC secretion and HDL-PC uptake by hepatocytes. Pemt2/2 and
Mdr22/2/Pemt2/2mice were fed the CS diet for 24 hr and then fed the choline-de-
ficient (CD) diet for 2 (Pemt2/2) or 21 (Mdr22/2/Pemt2/2) days. VLDL-PC secretion:
hepatocytes were labeled with [3H]choline for 2 hr and then the radiolabel was
chased for 2 hr. Medium was collected and [3H]PC was isolated from VLDL.
HDL-PC uptake: hepatocytes were incubated for 2 hr with mouse plasma HDL
that had been incubated with BODIPY-PC (fluorescent PC). HDL-PC uptake was
determined by measurement of intracellular fluorescence intensity. The values
are averages from 3 preparations of hepatocytes.
C) In vitro assay of calcium-dependent PLA2 (cPLA2) and calcium-independent
PLA2 (iPLA2) activities in liver homogenates from Pemt
2/2 and Mdr22/2/
Pemt2/2mice fed the CD diet, using as a substrate PED6 [(N-(6-(2,4-dinitrophenyl)
amino)hexanoyl)-2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-
pentanoyl)]-1-hexadecanoyl-sn-glycero-3-phosphoethanolamine.The values are
averages from 6–8 mice 6 SD, p < 0.05.CELL METABOLISM : MAY 2006
PC/PE ratio and steatohepatitisFigure 4. The PC/PE ratio influences membrane in-
tegrity of large unilamellar vesicles and hepatocytes
A) Permeability assays of large unilamellar vesicles
containing different PC/PE ratios. Vesicles (100 nm
in diameter) were prepared with PC/PE ratios of 0.5
to 2.0. The ratio among the content of hepatic (PC +
PE), sphingomyelin, and cholesterol was 86:1:9.
Leakage wasmeasured by the release of entrapped
calcein and normalized to the amount of calcein re-
leased by TritonX-100. Three independent experi-
ments were performed. Data are averages 6 SD.
B) Attenuation of PE biosynthesis by RNA interfer-
ence targeted to CTP: phosphoethanolamine cytidy-
lyltransferase (ET). Hepatocytes from CD-Pemt2/2
mice were transfected with ETi or control vectors
and were cotransfected with green fluorescent pro-
tein vectors (ratio, 4:1) for 24 or 48 hr. (Lower panel)
PE levels in hepatocytes. Data are averages 6 SD
from 3 experiments. *, p < 0.05. (Upper panel) PE bio-
synthesis in hepatocytes. Hepatocytes from CD-
Pemt2/2 mice were labeled with [3H]ethanolamine
after transfection with ETi for 24 hr and incorporation
of radiolabel into PE was measured. Data are aver-
ages 6 SD from 3 experiments.
C) The PC/PE ratio and cell damage in hepatocytes
treated with interfering RNA targeted to CTP: phos-
phoethanolamine cytidylyltransferase (ETi). ETi vec-
tor was cotransfected with green fluorescent protein
vector (ratio, 4:1) for 24 or 48 hr into hepatocytes iso-
lated from Pemt2/2 mice fed the CD diet for 2 days.
The medium was replaced with fresh medium for an
additional 4 hr. The hepatocytes were harvested and
the amounts of PC and PE determined. ALT activity
in the medium was measured as an indicator of cell
damage. Data are averages 6 SD from 3 experi-
ments. *, p < 0.05.
D) PE exposure on the surface of hepatocytes
treated with ETi. After transfection for 24 or 48 hr,
hepatocytes from CD-Pemt2/2mice were incubated
with biotinylated PE-specific binding peptide, Ro98-
019, at 4ºC for 30 min and subsequently with Texas
Red-conjugated streptavidin for 30 min. Cells were
examined by fluorescence microscopy. Green fluo-
rescence protein (green); PE binding fluorescence
(red). Data are from one experiment, representative
of three similar experiments.
E) Inhibition of PE catabolism-induced cell damage
in CD-Mdr22/2/Pemt2/2 mouse hepatocytes.
Arachidonyl trifluoromethyl ketone (ATK), a PLA2-
specific inhibitor, was added to CD medium (CD+
ATK) for 24 hr and 48 hr. The medium was replaced
with fresh medium every 2 hr during the first 8 hr to
remove secreted PC. After 4 hr incubation with fresh
medium, the cells and medium were harvested. (Up-
per panel) ALT activity in the medium was measured
as an indicator of cell damage. (Lower panel) PC and
PE in the hepatocytes were measured and the ratio
calculated. Data are averages from 3 independent
experiments. *, p < 0.01.We next investigated if hepatocyte damage could be reduced
in CD-Pemt2/2 mouse hepatocytes when PE synthesis was
attenuated. We used RNA interference (RNAi) with a vector tar-
geted to ET (ETi) to inhibit PE biosynthesis. Hepatocytes were
isolated from Pemt2/2 mice fed the CD diet for 2 days. Four
hours after plating, the hepatocytes were transfectedwith a vec-
tor encoding green fluorescent protein and either the control
vector or the ETi vector for 24 hr or 48 hr. ETi effectively de-
creased ET mRNA (by 71% after 24 hr and by 75% after 48 hr)
and ET activity (by 55% after 24 hr and by 37% after 48 hrCELL METABOLISM : MAY 2006(data not shown), and reduced the incorporation of [3H]ethanol-
amine into PE by 46% after transfection with control or ETi
vectors (Figure 4B). The concentration of PE in hepatocytes
from CD-Pemt2/2 mice was also reduced after transfection
with ETi by 25% after 24 hr and by 45% after 48 hr, P < 0.05
(Figure 4B) with a corresponding increase in the PC/PE ratio
after 24 hr and 48 hr (Figure 4C). The increased PC/PE ratio cor-
related with both a decreased exposure of PE on the hepatocyte
surface (Figure 4D) and a decreased leakage of ALT into the me-
dium (Figure 4C). Thus, in hepatocytes from CD-Pemt2/2mice,325
A R T I C L EFigure 5. Choline supplementation reverses steatosis and steatohepatitis induced in CD-Pemt2/2 mice
Pemt2/2 mice and Mdr22/2/Pemt2/2 mice were fed the CS diet for 24 hr and then fed the choline-deficient (CD) diet for 3 (CD3) or 21 (CD21) days. Some CD3-Pemt2/2
mice were subsequently fed the CS diet for 4 days (CD3 + CS4).
A) Livers from Pemt2/2 mice and Mdr22/2/Pemt2/2 mice.
B) Liver histology as indicated by hemotoxylin and eosin staining.
C and D) Hepatic PC and PE levels and PC/PE molar ratios. Values are averages 6 SD; *, p < 0.05; **, p < 0.01, for CS versus CD mice, 3–8 mice in each group.inhibition of PE biosynthesis increased the PC/PE ratio and in-
creased membrane integrity.
In an alternative approach, we increased the PE content of he-
patocytes fromCD-Mdr22/2/Pemt2/2mice. An inhibitor of PLA2
(arachidonyl trifluoromethyl ketone) was added to the medium
to block PC and PE degradation. Hepatocytes were cultured
in CD medium and secreted PC removed at various times.
Figure 4E shows that the PLA2 inhibitor lowered the PC/PE ratio
and stimulated ALT release during 24 and 48 hr. Thus, attenua-
tion of PE catabolism in CD-Mdr22/2/Pemt2/2 hepatocytes de-
creases the PC/PE ratio and increases hepatocyte damage.
The PC/PE ratio regulates the evolution of steatosis
into steatohepatitis
Multiple ‘‘hit’’ models have been proposed for the pathogenesis
of nonalcoholic fatty liver disease, but no distinct mechanism
has been shown to promote the change from the relatively
benign disorder, steatosis, into progressive liver disease associ-326ated with steatohepatitis (Koteish and Diehl, 2001; Koteish and
Mae Diehl, 2002; Cortez-Pinto et al., 2006). The modulation of
PC/PE ratio is a potential candidate for this process since the di-
minished ratio differentiates steatosis from steatohepatitis and
liver injury. Patients with NASH disease are evaluated histolog-
ically by grading the extent of hepatocyte ballooning, steatosis,
and lobular inflammation (Brunt, 2001; 2004); themodified Brunt
criteria were used to grade the steatohepatitis in Pemt2/2mice.
Pemt2/2 mice fed the CD diet died of hyperacute liver failure
with panlobular 3+macrovesicular steatosis, 2+ hepatocyte bal-
looning, Mallories hyaline and 3+ panacinar inflammation (Fig-
ures 5A and 5B) (Walkey et al., 1998). In contrast, Mdr22/2/
Pemt2/2 mice developed 2+ microvesicular steatosis in zone
3 after being fed the CD diet for 3 days, and 3+ macrovesicular
steatosis in all zones without lobular inflammation (0) or hepato-
cyte ballooning (0) by 21 days (Figures 5A and 5B). Thus, the
decreased PC/PE ratio (Figure 1C) correlated with grade 2 and
grade 3 steatohepatitis (NASH), but not grade 1 steatosis.CELL METABOLISM : MAY 2006
PC/PE ratio and steatohepatitisFigure 6. An increased PC/PE ratio reverses steatohepatitis, but not steatosis, induced by choline deficiency in Pemt2/2 mice
Saline (control) or ETi vectors (ETi) (50mg/kg), were injected three times into tail veins ofPemt2/2mice over a 24 hr period. Themicewere fed the CD diet for 2 days. Data for
each vector are from 3 mice and are the averages 6 SD.
A) Histological staining of livers by hemotoxylin and eosin.
B) Hepatic damage as assessed by plasma ALT activity. Values are averages 6 SD; **, p < 0.01.
C) Hepatic PC and PE levels; Values are averages 6 SD; *, p < 0.05.
D)Decreased hepatic PC/PE ratios in NASH patients. Liver biopsy sampleswere collected from four healthy persons (control) and nine NASH patients, andPC and PEwere
quantified. p = 0.001.A normal PC/PE ratio was maintained in wild-type mice fed the
CD diet for 21 days, where steatosis developed without inflam-
mation or ballooning degeneration (data not shown).
In Pemt2/2mice, a CS diet reversed the liver damage caused
by choline deficiency (Waite et al., 2002). The steatohepatitis in
CD-Pemt2/2micewasmarkedly attenuated and the PC/PE ratio
returned to normal when CD-Pemt2/2 mice were fed choline
(Figures 5C and 5D). Moreover, normalization of the PC level
(Figure 5C) coincidedwith reversal of panlobular macrovesicular
fat deposition to normal as indicated by histology (Figures 5A
and 5B), and normalizaton of hepatic triacylglycerol levels and
plasma ALT activity (data not shown).
Figure 4 shows that transfection with ETi increases the PC/PE
ratio and attenuates cell damage in CD-Pemt2/2 hepatocytes
by decreasing the amount of PE. To determine if a similar result
were observed in mice, we injected the ETi vector via the tail-
vein into CD-Pemt2/2 mice using a hydrodynamic protocol
that results in efficient delivery of the vector to the liver (Kobaya-
shi et al., 2004; Song et al., 2002). Mice were injected 3 times
over a 24 hr period and then fed the CD diet for 2 days prior to
sacrifice. The ETi prevented steatohepatitis but not steatosis
as indicated by Figures 5A, 6A, and 6B and caused no change
in the level of triacylglycerol (w500 mg/mg hepatic protein).
The PC/PE ratio in the liver was increased by the ETi injections
but the PC level did not change (Figure 6C), consistent with
the idea that fat accumulation in the liver depends on hepatic
PC levels. These data suggest that an increased PC/PE ratio
in vivo can reverse steatohepatitis, but not steatosis. However,
an increased amount of hepatic PC can attenuate steatosis.CELL METABOLISM : MAY 2006The potential relevance of these studies to human disease is
indicated in a pilot study of NASH patients. We found that he-
patic PC/PE ratios in NASH patients were significantly lower
than those in healthy human subjects (P = 0.001) (Figure 6D).
Discussion
Our results suggest that the PC/PE ratio is a critical modulator of
membrane integrity. A gradual decrease in hepatic PC in wild-
type and Mdr22/2/Pemt2/2 mice upon choline deprivation pro-
vides sufficient time for PC and PE metabolism to be modified
so that a normal PC/PE ratio ismaintained and liver failure is pre-
vented. On the other hand, in Pemt2/2mice, the CD diet causes
a decline in hepatic PC that is too rapid for metabolic adjust-
ments to be made. Consequently, the PC/PE ratio decreases
and liver damage occurs. Support for our hypothesis comes
from studies in which choline deprivation similarly decreased
the amount of PC, but not PE, in PC12 cells, resulting in cell
death (Yen et al., 1999). Moreover, an increase in PE, but not
PC, damaged heart myocytes as indicated by leakage of the
cytosolic enzyme lactate dehydrogenase (Post et al., 1995). It
would, therefore, be intriguing to know if variations in the PC/
PE ratio affect membrane integrity in other cell types.
A current model of NASH is to feed rodents a methionine- and
choline-deficient (MCD) diet (Koteish andMaeDiehl, 2002;Welt-
man et al., 1996). Although no previous reports have noted a
correlation between the PC/PE ratio and steatohepatitis, livers
from these animals had a decreased content of PC levels but
no change or aminor increase in the amount of PE (Beare-Rogers,327
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ratio was decreased. Livers from MCD murine models have
a reduced rate of PC and choline biosynthesis and mimic CD-
Pemt2/2 mice. Since S-adenosylmethionine is derived from
methionine and is a substrate of PEMT, dietary deprivation of
methionine attenuates the PEMT pathway. Although liver failure
and steatohepatitis occurred within 3 days in CD-Pemt2/2mice,
a similar degree of steatohepatitis did not develop until w3
months in MCD mice (Koteish and Mae Diehl, 2002; Weltman
et al., 1996), probably because the PEMT pathway was incom-
pletely blocked. Moreover, methionine can be made de novo
from betaine or methyltetrahydrofolate (Finkelstein and Martin,
1986). Therefore, the PC/PE ratio was decreased gradually
over 3months inMCD-wild-typemice as comparedwith acutely
(over 3 days) in CD-Pemt2/2mice (Beare-Rogers, 1971; Lyman
et al., 1973; Yost et al., 1985).
The current data certainly support the hypothesis that a de-
creased ratio of PC/PE is important for the evolution of steatosis
into steatohepatitis. A decreased PC/PE ratio adversely affects
membrane integrity, resulting in liver damage. We cannot be
sure if the change in the PC/PE ratio initiates or is the end point
of inflammation. Since we were able to reverse the decrease in
PC/PE ratio and thereby attenuate liver damage, we speculate
that this ratio is fundamentally important in the disease process.
A decreased PC/PE ratio correlates with a small decrease in
membrane potential of hepatocyte plasma membranes (data
not shown). A change of membrane potential was suggested
to initiate inflammation since the flow of ions (such as calcium)
and ion radicals varies during changes in membrane potential
(Curry, 1992; Kmiec, 2001). A loss of membrane integrity not
only leads to the release of cellular contents, but also increases
the influxof extracellular components including cytokines (Curry,
1992; Kmiec, 2001). In addition, C-reactive protein, an acute
inflammatory response protein, binds more avidly to cell mem-
branes in which the PC/PE ratio is decreased (Mold, 1989).
Therefore, a decreased PC/PE ratio might initiate inflammation.
The factors that promote hepatocyte damage and inflamma-
tion in the progression of steatosis to steatohepatitis have yet to
be resolved in humans. Our initial results with human subjects
indicate that the PC/PE ratio is altered in many patients with
NASH. It will be important to determine if the PC/PE ratio is
also decreased in patients with other chronic liver disorders,
such as alcoholic liver disease as well as those presenting
with fatty liver and acute liver failure associated with pregnancy
and drug toxicity. The mouse models used in our research sug-
gest mechanisms that determine what regulates the transition
from steatosis to steatohepatitis in humans. Our results not
only provide a clue to the mechanisms involved in the develop-
ment of steatohepatitis but also suggest that boosting hepatic
PC levels and/or reducing the hepatic PE level may provide




Mdr22/2/Pemt2/2 mice were produced by breeding Pemt2/2 mice (C57BL/
6; 129/J background) (Walkey et al., 1997) with Mdr22/2mice (FVB; 129/
J background) (Smit et al., 1993). The mice were fed a CD diet (ICN,
Cat#0290138710) or a CS diet, the CD diet supplemented with 0.4% (w/w)
choline chloride. At the age of 10–12 weeks, Pemt2/2 and Mdr22/2/Pemt2/2
mice were fed the CS diet for 24 hr then fed the CD diet for 3, 21, or 90328days. Mdr22/2/Pemt2/2 mice did not develop intrahepatic cholestasis nor
show any liver damage in the first 5 months after birth, which covered the pe-
riod of this experiment (10–12 weeks of age + 3 weeks treatment). In choline
refeeding experiments, after being fed the CD diet for 3 days, Pemt2/2mice
were fed the CS diet for an additional 4 days. In experiments in which ET was
suppressed by RNAi (ETi), chow diet-fed Pemt2/2 mice were hydrodynami-
cally injected via the tail with 1 ml saline (control) or ETi vectors (50mg/kg)
at 0, 8, and 24 hr. All mice were fasted for 12 hr before sacrifice. Three to eight
mice were used for each time point in each experiment with assays in dupli-
cate. All data are means 6 SD.
Sample collections
Livers were frozen in liquid N2 after dissection. Blood was collected by car-
diac puncture with instruments pretreatedwith EDTA. Plasmawas separated
by centrifugation at 2000 rpm for 20 min in a refrigerated bench-top centri-
fuge. Bile was collected from the intact gall bladders. All samples were stored
at 270ºC before use.
Analysis of phospholipid composition in human livers
Nine liver samples from NASH patients (age 41 6 12) were used. Controls
were four healthy individuals (age 50 6 13). The pathological diagnosis of
NASH after liver biopsy was in accordance with Kleiner et al. (2005). In all
subjects, the diagnosis of NASHwasmade following the exclusion of causes
of chronic hepatitis including hepatitis B, hepatitis C, a-1 antitrypsin defi-
ciency, autoimmune hepatitis, Wilson’s disease, drug toxicity, total paren-
teral nutrition, and chronic alcohol intake. Phospholipids in the liver homog-
enates were measured as indicated below. The protocol was approved by
the Health Research Ethics Board of the University of Alberta.
Genotyping
As PCR templates, genomic DNA from mice tails was extracted with
a DNeasy Tissue Kit (Qiagen). PCR was used to distinguish between wild-
type and targeted alleles containing a neomycin resistance gene (neo).
Primer sequences: for the Pemt gene were, forward primer (F): 50-GAGCGC
AATGGTACTCACCACATTCC, reverse primer (R): 50- GATCTTGTCTTCAGA
GCCACAG; for the Pemt knockout allele, F: 50- GAGCGCAATGGTACTCACC
ACATTCC, R: 50-CTCGACGTTGTCGAAG; for the Mdr2 allele, F: 50-GCTG
AGATGGATCTTGAG, R: 50-GTCGAGTAGCCAGATGATGG; for the Mdr2
knockout allele, F: 50-CGGCGAGGATCTCGTCGTGACCCA, R: 50-GCGAT
ACCGTAAAGCACGAGGAAG.
Preparation of primary hepatocytes
Primary hepatocytes were isolated (Noga et al., 2002) from Pemt2/2 and
Mdr22/2/Pemt2/2 mice fed the CS diet for 24 hr and then fed the choline-
deficient (CD). Pemt2/2 mice were fed the CD diet for 2 days and Mdr22/2/
Pemt2/2 mice were fed the CD diet for 3 or 21 days. Hepatocytes were cul-
tured in either Dulbecco’s modified Eagle’s medium (DMEM) containing 4
mg/l choline (CSmedium) or CDmedium (the samemediumwithout choline).
Ethanolamine (4 mg/l) was added to both CS and CD medium. Three prepa-
rations of hepatocytes were used in each experiment.
Lipid analyses
Livers were homogenized with a Polytron in 5 vol 10 mM Tris-HCl, (pH 7.2),
150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl
fluoride, 1:100 protease inhibitor cocktail (Sigma, Cat#P8340). Homogenates
were centrifuged for 5 min at 600 3 g and supernatants collected. Protein
was quantified (Bradford, 1976) and total lipids were extracted from liver ho-
mogenates (Bligh and Dyer, 1959). Phospholipids were separated by high-
performance liquid chromatography and quantified with an electron-light
scattering detector (McCluer et al., 1986). Phosphatidyldimethylethanol-
amine was used as an internal standard for quantification. Neutral lipids, in-
cluding triacylglycerols, cholesterol and cholesteryl esters, were measured
by gas-liquid chromatography (Lohninger et al., 1990).
Enzyme assays
Plasma aspartate and alanine aminotransferases (AST/ALT) were assayed
with a GPT/GOT Kit (Sigma, Cat#P505). ET activity was measured in total
cell homogenates (Tijburg et al., 1992). The substrate for the ET assay,
[3H]phosphoethanolamine, was made from [3H]ethanolamine by phosphory-
lation with choline/ethanolamine kinase. Phospholipase A2 (PLA2) activitiesCELL METABOLISM : MAY 2006
PC/PE ratio and steatohepatitiswere measured in liver homogenates and primary hepatocytes with PED6
[(N-(6-(2,4-dinitrophenyl)amino)hexanoyl)-2-(4,4-difluoro-5,7-dimethyl-4-bora-
3a,4a-diaza-s-indacene-3-pentanoyl)]-1-hexadecanoyl-sn-glycero-3-phos-
phoethanolamine, triethylammonium salt (Molecular Probes), a self-quench-
ing fluorescent analog of PE and a PLA2-specific substrate (Farber et al.,
2001). The specificity of PLA2 activity was further confirmed by in vitro assay
in the presence of 50 mmol/l PLA2 inhibitors, BEL (an iPLA2-specific inhibitor)
(Hazen et al., 1991) or ATK (an inhibitor of both iPLA2 and cPLA2) (Street
et al., 1993).
Preparation of hepatocyte plasma membranes and assessment
of purity
Hepatocytes were incubated with colloidal silica and plasma membranes
were isolated by differential centrifugation (Chaney and Jacobson, 1983;
Garver et al., 2002). Purity of plasma membrane fractions was assessed by
enrichment of the plasma membrane marker (50-nucleotidase). The degree
of contamination by endoplasmic reticulum membranes was assessed by
determination of NADPH:cytochrome C reductase activity (Croze andMorre,
1984).
Assay of fluidity and potential of plasma membrane
Membrane fluidity in the plasma membrane of hepatocytes was assessed
by incubation of hepatocytes with 1-(4-trimethylammoniumphenyl)-6-phe-
nyl-1,3,5-hexatriene p-tolunesulfonate (Molecular Probes) at 4ºC for 10 min
and subsequently analyzed with a fluorimeter within 1 min. The fluorescence
polarization value was calculated with the formula of p = (F parallel 2 F per-
pendicular) / (F parallel + F perpendicular) (Ferretti et al., 1993; McKinley and
Hazel, 2000; Yamada et al., 2001). Membrane potential was assayed by in-
cubation of hepatocytes with bis-(1,3-dibutylbarbituric acid)trimethine oxo-
nol (3) at 4ºC for 30 min. Fluorescence was analyzed with a fluorimeter within
1min and fluorescence intensity per cell was determined (Ferretti et al., 1993;
Yamada et al., 2001).
Detection of PE on the cell surface of hepatocytes
Primary cultured hepatocytes were incubated with the biotinylated PE-spe-
cific binding peptide, Ro98-019, at 4ºC for 30 min and subsequently with
FITC-conjugated streptavidin for 30 min. Fluorescence was visualized by
fluorescence microscopy (Emoto et al., 1997). Relative fluorescent intensity
was measured by flow cytometry.
Measurement of PE synthesis and degradation
Primary hepatocytes from Mdr22/2/Pemt2/2 mice were incubated with
[3H]glycerol for 2 hr and then radioactivity was chased for 2 hr. The rates of
PE synthesis and degradation were calculated as described previously (Ko
et al., 1986). PE biosynthetic rate = (dpm in PE at end of the pulse/mg protein) /
(2 hr 3 nmol PE/mg protein at the beginning of the pulse). PE degradation
rate = (decrease in dpm in PE between the end of the pulse and 2 hr of
chase/mg protein) / (2 hr 3 nmole of PE/mg protein). The relative rates are
compared between CS and CD.
VLDL-PC secretion and HDL-PC uptake
VLDL-PC secretion assay: CS and CD hepatocytes from Pemt2/2 and
Mdr22/2/Pemt2/2mice were labeled with [3H]choline for 2 hr and then radio-
activity was chased for 2 hr. Cell culture medium was harvested and VLDL
were isolated by sucrose gradient centrifugation (Chung et al., 1980). Total
lipids were extracted from VLDL (Bligh and Dyer, 1959), and [3H]PC was sep-
arated by thin-layer chromatography. The rate of VLDL-PC secretion (dpm/h/
1 3 106 cells) was calculated from four time points during the chase.
HDL-PC uptake assay: HDL were isolated from plasma of wild-type mice
by sucrose gradient centrifugation and preincubated with fluorescence-
labeled PC (BODIPY-PC) from Molecular Probes (Chung et al., 1980; Jeong
et al., 1998). Primary cultured hepatocytes were incubated with [BODIPY-
PC]HDL for 2 hr and then cells were washed three times. Intracellular fluores-
cence intensity was measured by a fluorimeter. The rate of HDL-PC uptake
(change in fluorescence intensity/h/1 3 106 cells) was calculated from four
time points during the 2 hr incubation.
Permeability assays of large unilamellar vesicles
Hepatic PC and PE (Avanti) were used tomake large unilamellar vesicles with
PC/PE ratios of 0.5, 1.0, 1.5, and 2.0. [PC +PE] weremixedwith sphingomye-CELL METABOLISM : MAY 2006lin and cholesterol in a ratio of 86:1:9. Lipids were hydrated in Tris-HCl buffer
(pH 9.0) in the presence of calcein (50mM), a concentration at which the fluo-
rescence of calcein is highly quenched. Large unilamellar vesicles were pre-
pared at 55ºCwith an extruder (Lipex Biomembranes) and 100 nmNuclepore
filters (Allen et al., 1985; Haque et al., 2001). Large unilamellar vesicles were
separated from untrapped calcein by chromatography over a Sephadex G-
75 column. The diameter of the vesicles was measured by a light-scattering
photometer and was 100 nm (Allen et al., 1985; Haque et al., 2001). The per-
meability assay measured the fluorescence of calcein accompanying its
de-quenching upon release from the vesicles in Tris-HCl buffer (pH 7.4).
The fluorescence intensity corresponding to 100% leakage was determined
by adding 10% Triton X-100 to solubilize the membranes (Allen et al., 1985;
Haque et al., 2001).
RNA interference (RNAi) of ET in cultured hepatocytes
RNAi sequence, 50-AAGCACAACTGTGACTTCTCT-30, targeted to themRNA
of mouse ET, was inserted into pSilencer 4.1-CMV vectors (Ambion) to pro-
duce ETi vectors. A control sequence from ETi, 50-AATGACAGCTAGCACT
GAGCT-30, was inserted into the pSilencer 4.1-CMV vector to produce an ETi
control vector. Lipofectamine 2000 (Invitrogen) was used as carrier for trans-
fection. ETi and control vectors were cotransfected for 24 or 48 hr with GFP
vectors (ratio, 4:1) into cultured hepatocytes isolated fromCD-Pemt2/2mice.
Hepatic RNA was extracted and mRNA levels of ET were quantitated relative
to cyclophilin mRNA by SYBR Green assays using real-time qPCR. Primer
sequences for ET: forward primer, 50-AGCTAGCCAAGAGGCCCTAC-30; re-
verse primer, 50-CACCAGGTCCACCTTGAAGT-30. Primer sequences for cy-
clophilin: forward primer, 50-TCCAAAGACAGCAGAAAACTTTCG-30; reverse
primer, 50-TCTTCTTGCTGGTCTTGCCATTCC-30. After transfection for 20 or
44 hr, cells were incubated with fresh medium and cultured for 4 hr.
Inhibition of PE catabolism by arachidonyl trifluoromethyl
ketone (ATK)
Primary hepatocytes from Mdr22/2/Pemt2/2 mice were cultured in medium
that contained 17% delipidated fetal bovine serum in Dulbecco’s modified
Eagle’s medium that was choline-deficient. The medium was changed every
2 hr during the first 8 hr to remove any secreted PC since secreted PC might
have been reused. Arachidonyl trifluoromethyl ketone (ATK), a PLA2-specific
inhibitor (50 mmol/l) was added to the CD medium for 24 or 48 hr to block the
degradation of phospholipids (including PE). After 20 or 44 hr, medium was
replaced with fresh medium and cells were cultured for 4 hr.
Histological and pathological analyses
Liver tissues from three mice per experiment were fixed in 10% formalin and
stained with hemotoxylin and eosin. Coded sections were evaluated by a pa-
thologist and a hepatologist. The modified Brunt criteria were used to grade
the steatosis, hepatocyte ballooning and lobular inflammation in a scale of
0 to 3 and reported as median score for each parameter as well as overall
grade (Brunt, 2001; 2004). Consecutive liver biopsy samples were derived
and frozen at 280ºC from patients with a histological diagnosis of NASH,
once other viral, autoimmune, toxic, genetic, and miscellaneous hepatic di-
agnoses were excluded.
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